-   directed: true
    graph:
        drug: Acetophenazine
        drugbank: DB:DB01063
        drug_mesh: MESH:C100162
        disease: Psychotic disorder
        disease_mesh: MESH:D011618
    links:
    -   key: decreases activity of
        source: MESH:C100162
        target: UniProt:P21728
    -   key: located in
        source: UniProt:P21728
        target: UBERON:0000955
    -   key: decreases activity of
        source: MESH:C100162
        target: UniProt:P14416
    -   key: located in
        source: UniProt:P14416
        target: UBERON:0000955
    -   key: decreases secretion of
        source: UBERON:0000955
        target: InterPro:IPR022423
    -   key: positively correlated with
        source: InterPro:IPR022423
        target: HP:0000708
    -   key: correlated with
        source: HP:0000708
        target: MESH:D011618
    multigraph: true
    nodes:
    -   id: MESH:C100162
        label: Drug
        name: Acetophenazine
    -   id: UniProt:P21728
        label: Protein
        name: Dopaminergic D1 receptors
    -   id: UniProt:P14416
        label: Protein
        name: Dopaminergic D2 receptors
    -   id: UBERON:0000955
        label: GrossAnatomicalStructure
        name: Brain
    -   id: InterPro:IPR022423
        label: GeneFamily
        name: Neurohypophysial hormone
    -   id: HP:0000708
        label: PhenotypicFeature
        name: Behavior
    -   id: MESH:D011618
        label: Disease
        name: Psychotic disorder
    reference: https://go.drugbank.com/drugs/DB01063#mechanismofaction
-   directed: true
    graph:
        drug: Fidaxomicin
        drugbank: DB:DB08874
        drug_mesh: NULL
        disease: Pseudomembranous enterocolitis
        disease_mesh: MESH:D004761
    links:
    -   key: decreases activity of
        source: DB:DB08874
        target: PR:000026806
    -   key: disrupts
        source: PR:000026806
        target: GO:0001121
    -   key: in taxon
        source: GO:0001121
        target: NCBITaxon:1496
    -   key: causes
        source: NCBITaxon:1496
        target: MESH:D004761
    multigraph: true
    nodes:
    -   id: DB:DB08874
        label: Drug
        name: Fidaxomicin
    -   id: PR:000026806
        label: MacromolecularComplex
        name: DNA template-RNA polymerase complex
    -   id: GO:0001121
        label: BiologicalProcess
        name: Bacterial transcription
    -   id: NCBITaxon:1496
        label: OrganismTaxon
        name: Clostridioides difficile
    -   id: MESH:D004761
        label: Disease
        name: Pseudomembranous enterocolitis
    reference: https://go.drugbank.com/drugs/DB08874#mechanismofaction
-   directed: true
    graph:
        drug: Fidaxomicin
        drugbank: DB:DB08874
        drug_mesh: NULL
        disease: Clostridium difficile infection
        disease_mesh: MESH:D003015
    links:
    -   key: decreases activity of
        source: DB:DB08874
        target: PR:000026806
    -   key: disrupts
        source: PR:000026806
        target: GO:0001121
    -   key: in taxon
        source: GO:0001121
        target: NCBITaxon:1496
    -   key: causes
        source: NCBITaxon:1496
        target: MESH:D003015
    multigraph: true
    nodes:
    -   id: DB:DB08874
        label: Drug
        name: Fidaxomicin
    -   id: PR:000026806
        label: MacromolecularComplex
        name: DNA template-RNA polymerase complex
    -   id: GO:0001121
        label: BiologicalProcess
        name: Bacterial transcription
    -   id: NCBITaxon:1496
        label: OrganismTaxon
        name: Clostridioides difficile
    -   id: MESH:D003015
        label: Disease
        name: Clostridium difficile infection
    reference: https://go.drugbank.com/drugs/DB08874#mechanismofaction
-   directed: true
    comment: Goserelin is a synthetic hormone
    graph:
        drug: Goserelin
        drugbank: DB:DB00014
        drug_mesh: MESH:D017273
        disease: Endometriosis
        disease_mesh: MESH:D004715
    links:
    -   key: increases activity of
        source: MESH:D017273
        target: UniProt:P30968
    -   key: located in
        source: UniProt:P30968
        target: UBERON:0000007
    -   key: negatively regulates
        source: UBERON:0000007
        target: GO:0032274
    -   key: decreases abundance of
        source: GO:0032274
        target: MESH:D004958
    -   key: manifestation of
        source: MESH:D004958
        target: MESH:D004715
    -   key: decreases abundance of
        source: GO:0032274
        target: MESH:D011374
    -   key: manifestation of
        source: MESH:D011374
        target: MESH:D004715
    multigraph: true
    nodes:
    -   id: MESH:D017273
        label: Drug
        name: Goserelin
    -   id: UniProt:P30968
        label: Protein
        name: Gonadotropin releasing hormone (GnRH) receptors
    -   id: MESH:D011374
        label: ChemicalSubstance
        name: Progesterone
    -   id: UBERON:0000007
        label: GrossAnatomicalStructure
        name: Pituitary
    -   id: GO:0032274
        label: BiologicalProcess
        name: Gonadotropin secretion
    -   id: MESH:D004958
        label: ChemicalSubstance
        name: Estradiol 
    -   id: MESH:D004715
        label: Disease
        name: Endometriosis
    reference: https://go.drugbank.com/drugs/DB00014#mechanismofaction https://pubchem.ncbi.nlm.nih.gov/compound/Goserelin#section=Pharmacology-and-Biochemistry http://www.bccancer.bc.ca/drug-database-site/Drug%20Index/Goserelin_monograph_1Aug2012_formatted.pdf

-   directed: true
    graph:
        drug: Interferon beta-1b
        drugbank: DB:DB00068
        drug_mesh: MESH:D000068576
        disease: Relapsing remitting multiple sclerosis
        disease_mesh: MESH:D020529
    links:
    -   key: increases activity of
        source: MESH:D000068576
        target: UniProt:P17181
    -   key: positively regulates
        source: UniProt:P17181
        target: REACT:R-HSA-8950505
    -   key: increases activity of
        source: MESH:D000068576
        target: UniProt:P48551
    -   key: positively regulates
        source: UniProt:P48551
        target: REACT:R-HSA-8950505
    -   key: regulates
        source: REACT:R-HSA-8950505
        target: GO:0002369
    -   key: regulates
        source: GO:0002369
        target: GO:0001768
    -   key: ameliorates
        source: GO:0001768
        target: GO:0006954
    -   key: located in
        source: GO:0006954
        target: CL:0000540
    -   key: decreases activity of
        source: REACT:R-HSA-8950505
        target: GO:0019882
    -   key: regulates
        source: GO:0019882
        target: GO:0001768
    -   key: ameliorates
        source: GO:0001768
        target: GO:0052572
    -   key: located in
        source: GO:0052572
        target: CL:0000540
    -   key: correlated with
        source: CL:0000540
        target: MESH:D020529
    multigraph: true
    nodes:
    -   id: MESH:D000068576
        label: Drug
        name: Interferon beta-1b
    -   id: UniProt:P17181
        label: Protein
        name: Interferon alpha/beta receptor 1
    -   id: REACT:R-HSA-8950505
        label: Pathway
        name: JAK/STAT signaling
    -   id: UniProt:P48551
        label: Protein
        name: Interferon alpha/beta receptor 2
    -   id: GO:0002369
        label: BiologicalProcess
        name: T cell cytokine production
    -   id: GO:0006954
        label: BiologicalProcess
        name: Inflammatory response
    -   id: GO:0019882
        label: BiologicalProcess
        name: Antigen presentation
    -   id: GO:0001768
        label: BiologicalProcess
        name: T cell polarization
    -   id: GO:0052572
        label: BiologicalProcess
        name: Host immune response
    -   id: CL:0000540
        label: Cell
        name: Neuron
    -   id: MESH:D020529
        label: Disease
        name: Relapsing remitting multiple sclerosis
    reference: https://go.drugbank.com/drugs/DB00068 DOI:10.1002/ana.21652 DOI:10.1212/01.wnl.0000277703.74115.d2 https://en.wikipedia.org/wiki/Interferon_beta-1a
-   directed: true
    comment: Dromostanolone Propionate is the propionate salt form of dromostanolone, which is less polar than free steroids, and are absorbed more slowly from the area of injection
    graph:
        drug: Drostanolone propionate
        drugbank: DB:DB14655
        drug_mesh: MESH:C007561
        disease: Malignant tumor of breast
        disease_mesh: MESH:D001943
    links:
    -   key: decreases activity of
        source: MESH:C007561
        target: UniProt:P16471
    -   key: decreases activity of
        source: UniProt:P16471
        target: UniProt:P10275
    -   key: decreases activity of
        source: MESH:C007561
        target: UniProt:P03372
    -   key: decreases activity of
        source: UniProt:P03372
        target: UniProt:P10275
    -   key: negatively regulates
        source: UniProt:P10275
        target: GO:0009063
    -   key: negatively correlated with
        source: GO:0009063
        target: GO:0002347
    -   key: positively regulates
        source: UniProt:P10275
        target: GO:0006412
    -   key: negatively correlated with
        source: GO:0006412
        target: GO:0002347
    -   key: causes
        source: GO:0002347
        target: MESH:D001943
    multigraph: true
    nodes:
    -   id: MESH:C007561
        label: Drug
        name: Drostanolone propionate
    -   id: UniProt:P16471
        label: Protein
        name: Prolactin receptors
    -   id: UniProt:P03372
        label: Protein
        name: Estrogen receptors
    -   id: GO:0009063
        label: BiologicalProcess
        name: Cellular amino acid catabolic process
    -   id: UniProt:P10275
        label: Protein
        name: Androgen receptor
    -   id: GO:0006412
        label: BiologicalProcess
        name: Protein synthesis
    -   id: GO:0002347
        label: BiologicalProcess
        name: Response to tumor cell
    -   id: MESH:D001943
        label: Disease
        name: Malignant tumor of breast
    reference: https://go.drugbank.com/drugs/DB14655 https://en.wikipedia.org/wiki/Drostanolone_propionate https://en.wikipedia.org/wiki/Anabolic_steroid#Mechanism_of_action


-   directed: true
    comment: Tacrine has been discontinued for the United States market.
    graph:
        drug: Tacrine
        drugbank: DB:DB00382
        drug_mesh: MESH:D013619
        disease: Alzheimer's disease
        disease_mesh: MESH:D000544
    links:
    -   key: decreases activity of
        source: MESH:D013619
        target: UniProt:P22303
    -   key: increases abundance of
        source: UniProt:P22303
        target: MESH:D000109
    -   key: located in
        source: MESH:D000109
        target: GO:0098981
    -   key: manifestation of
        source: GO:0098981
        target: MESH:D000544
    multigraph: true
    nodes:
    -   id: MESH:D013619
        label: Drug
        name: Tacrine
    -   id: UniProt:P22303
        label: Protein
        name: Cholinesterase
    -   id: MESH:D000109
        label: ChemicalSubstance
        name: Acetylcholine
    -   id: GO:0098981
        label: CellularComponent
        name: Cholinergic synapse
    -   id: MESH:D000544
        label: Disease
        name: Alzheimer's disease
    reference: https://go.drugbank.com/drugs/DB00382
-   directed: true
    graph:
        drug: Piperazine
        drugbank: DB:DB00592
        drug_mesh: NULL
        disease: Ascariasis
        disease_mesh: MESH:D001196
    links:
    -   key: increases activity of
        source: DB:DB00592
        target: UniProt:P28472
    -   key: positively correlated with
        source: UniProt:P28472
        target: GO:0005254
    -   key: decreases abundance of
        source: UniProt:P28472
        target: MESH:D000109
    -   key: occurs in
        source: MESH:D000109
        target: GO:0060081
    -   key: occurs in
        source: GO:0005254
        target: GO:0060081
    -   key: causes
        source: GO:0060081
        target: HP:0003470
    -   key: increases activity of
        source: HP:0003470
        target: GO:0098542
    -   key: in taxon
        source: GO:0098542
        target: NCBITaxon:6252
    -   key: causes
        source: NCBITaxon:6252
        target: MESH:D001196
    multigraph: true
    nodes:
    -   id: DB:DB00592
        label: Drug
        name: Piperazine
    -   id: UniProt:P28472
        label: Protein
        name: Gamma-aminobutyric acid receptor subunit beta-3
    -   id: GO:0005254
        label: BiologicalProcess
        name: Chloride channel activity
    -   id: MESH:D000109
        label: ChemicalSubstance
        name: Acetylcholine
    -   id: GO:0060081
        label: BiologicalProcess
        name: Membrane hyperpolarization
    -   id: HP:0003470
        label: PhenotypicFeature
        name: Paralysis
    -   id: GO:0098542
        label: BiologicalProcess
        name: Defense response to other organism
    -   id: NCBITaxon:6252
        label: OrganismTaxon
        name: Ascaris lumbricoides
    -   id: MESH:D001196
        label: Disease
        name: Ascariasis
    reference: https://go.drugbank.com/drugs/DB00592 https://pubchem.ncbi.nlm.nih.gov/compound/Piperazine#section=Pharmacology

-   directed: true
    graph:
        drug: Piperazine
        drugbank: DB:DB00592
        drug_mesh: NULL
        disease: Enterobiasis
        disease_mesh: MESH:D017229
    links:
    -   key: increases activity of
        source: DB:DB00592
        target: UniProt:P28472
    -   key: positively correlated with
        source: UniProt:P28472
        target: GO:0005254
    -   key: decreases abundance of
        source: UniProt:P28472
        target: MESH:D000109
    -   key: occurs in
        source: MESH:D000109
        target: GO:0060081
    -   key: occurs in
        source: GO:0005254
        target: GO:0060081
    -   key: causes
        source: GO:0060081
        target: HP:0003470
    -   key: increases activity of
        source: HP:0003470
        target: GO:0098542
    -   key: in taxon
        source: GO:0098542
        target: NCBITaxon:51028
    -   key: causes
        source: NCBITaxon:51028
        target: MESH:D017229
    multigraph: true
    nodes:
    -   id: DB:DB00592
        label: Drug
        name: Piperazine
    -   id: UniProt:P28472
        label: Protein
        name: Gamma-aminobutyric acid receptor subunit beta-3
    -   id: GO:0005254
        label: BiologicalProcess
        name: Chloride channel activity
    -   id: MESH:D000109
        label: ChemicalSubstance
        name: Acetylcholine
    -   id: GO:0060081
        label: BiologicalProcess
        name: Membrane hyperpolarization
    -   id: HP:0003470
        label: PhenotypicFeature
        name: Paralysis
    -   id: GO:0098542
        label: BiologicalProcess
        name: Defense response to other organism
    -   id: NCBITaxon:51028
        label: OrganismTaxon
        name: Enterobius vermicularis
    -   id: MESH:D017229
        label: Disease
        name: Enterobiasis
    reference: https://go.drugbank.com/drugs/DB00592 https://pubchem.ncbi.nlm.nih.gov/compound/Piperazine#section=Pharmacology

-   directed: true
    comment: Dromostanolone Propionate is the propionate salt form of dromostanolone, which is less polar than free steroids, and are absorbed more slowly from the area of injection
    graph:
        drug: Drostanolone propionate
        drugbank: DB:DB14655
        drug_mesh: MESH:C007561
        disease: Breast Neoplasms
        disease_mesh: MESH:D001943
    links:
    -   key: increases activity of
        source: MESH:C007561
        target: UniProt:P10275
    -   key: negatively regulates
        source: UniProt:P10275
        target: GO:0030520
    -   key: positively regulates
        source: GO:0030520
        target: GO:0008283
    -   key: positively correlated with
        source: GO:0008283
        target: MESH:D001943
    multigraph: true
    nodes:
    -   id: MESH:C007561
        label: Drug
        name: Drostanolone propionate
    -   id: UniProt:P10275
        label: Protein
        name: Androgen receptor
    -   id: GO:0030520
        label: BiologicalProcess
        name: Intracellular estrogen receptor signaling pathway
    -   id: GO:0008283
        label: BiologicalProcess
        name: Cell population proliferation 
    -   id: MESH:D001943
        label: Disease
        name: Breast Neoplasms
    reference: https://go.drugbank.com/drugs/DB14655 https://en.wikipedia.org/wiki/Drostanolone_propionate https://en.wikipedia.org/wiki/Anabolic_steroid#Mechanism_of_action
-   directed: true
    comment: Drostanolone, or dromostanolone, is an anabolic–androgenic steroid (AAS) of the dihydrotestosterone (DHT) group which was never marketed.
    graph:
        drug: Drostanolone
        drugbank: DB:DB00858
        drug_mesh: MESH:C100263
        disease: Breast Neoplasms
        disease_mesh: MESH:D001943
    links:
    -   key: increases activity of
        source: MESH:C100263
        target: UniProt:P10275
    -   key: negatively regulates
        source: UniProt:P10275
        target: GO:0030520
    -   key: positively regulates
        source: GO:0030520
        target: GO:0008283
    -   key: positively correlated with
        source: GO:0008283
        target: MESH:D001943
    multigraph: true
    nodes:
    -   id: MESH:C100263
        label: Drug
        name: Drostanolone
    -   id: UniProt:P10275
        label: Protein
        name: Androgen receptor
    -   id: GO:0030520
        label: BiologicalProcess
        name: Intracellular estrogen receptor signaling pathway
    -   id: GO:0008283
        label: BiologicalProcess
        name: Cell population proliferation 
    -   id: MESH:D001943
        label: Disease
        name: Breast Neoplasms
    reference: https://go.drugbank.com/drugs/DB00858 https://en.wikipedia.org/wiki/Drostanolone https://pubchem.ncbi.nlm.nih.gov/compound/Drostanolone https://en.wikipedia.org/wiki/Anabolic_steroid#Mechanism_of_action
-   directed: true
    graph:
        drug: Tetrabenazine
        drugbank: DB:DB04844
        drug_mesh: MESH:D013747
        disease: Huntington Disease
        disease_mesh: MESH:D006816
    links:
    -   key: decreases activity of
        source: MESH:D013747
        target: UniProt:Q05940
    -   key: decreases uptake of
        source: UniProt:Q05940
        target: GO:0015844
    -   key: located in
        source: GO:0015844
        target: GO:0008021
    -   key: ameliorates
        source: GO:0008021
        target: HP:0002072
    -   key: correlated with
        source: HP:0002072
        target: MESH:D006816
    multigraph: true
    nodes:
    -   id: MESH:D013747
        label: Drug
        name: Tetrabenazine
    -   id: UniProt:Q05940
        label: Protein
        name: Vesicular monoamine transporter 2
    -   id: GO:0015844
        label: BiologicalProcess
        name: Monoamine transport
    -   id: GO:0008021
        label: BiologicalProcess
        name: Synaptic vesicle
    -   id: HP:0002072
        label: PhenotypicFeature
        name: Chorea
    -   id: MESH:D006816
        label: Disease
        name: Huntington Disease
    reference: https://go.drugbank.com/drugs/DB04844 https://journals.sagepub.com/doi/pdf/10.4137/CMT.S2134
-   directed: true
    graph:
        drug: Tranilast
        drugbank: DB:DB07615
        drug_mesh: MESH:C012293
        disease: Asthma
        disease_mesh: MESH:D001249
    links:
    -   key: decreases activity of
        source: MESH:C012293
        target: GO:0001821
    -   key: location of
        source: GO:0001821
        target: CL:0000097
    -   key: ameliorates
        source: CL:0000097
        target: GO:0002524
    -   key: decreases activity of
        source: GO:0002524
        target: GO:0048144
    -   key: correlated with
        source: GO:0048144
        target: MESH:D001249
    multigraph: true
    nodes:
    -   id: MESH:C012293
        label: Drug
        name: Tranilast
    -   id: GO:0001821
        label: BiologicalProcess
        name: Histamine secretion
    -   id: CL:0000097
        label: Cell
        name: Mast cell
    -   id: GO:0002524
        label: BiologicalProcess
        name: Hypersensitivity
    -   id: GO:0048144
        label: BiologicalProcess
        name: Fibroblast proliferation
    -   id: MESH:D001249
        label: Disease
        name: Asthma
    reference: https://go.drugbank.com/drugs/DB07615 https://pubchem.ncbi.nlm.nih.gov/compound/Tranilast#section=MeSH-Pharmacological-Classification https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1527-3466.1998.tb00359.x https://newdrugapprovals.org/2020/02/28/tranilast/
-   directed: true
    graph:
        drug: Tranilast
        drugbank: DB:DB07615
        drug_mesh: MESH:C012293
        disease: Asthma
        disease_mesh: MESH:D001249
    links:
    -   key: decreases activity of
        source: MESH:C012293
        target: UniProt:P35354
    -   key: decreases activity of
        source: UniProt:P35354
        target: GO:0001516
    -   key: decreases abundance of
        source: GO:0001516
        target: MESH:D044062
    -   key: decreases activity of
        source: MESH:C012293
        target: MESH:D016207
    -   key: ameliorates
        source: MESH:D016207
        target: GO:0006954
    -   key: ameliorates
        source: MESH:D044062
        target: GO:0006954
    -   key: correlated with
        source: GO:0006954
        target: MESH:D001249
    multigraph: true
    nodes:
    -   id: MESH:C012293
        label: Drug
        name: Tranilast
    -   id: UniProt:P35354
        label: Protein
        name: Cyclooxygenase-2
    -   id: GO:0001516
        label: BiologicalProcess
        name: Prostaglandin biosynthetic process
    -   id: MESH:D016207
        label: BiologicalProcess
        name: Cytokines release
    -   id: MESH:D044062
        label: ChemicalSubstance
        name: Prostaglandins I
    -   id: GO:0006954
        label: BiologicalProcess
        name: Inflammatory response
    -   id: MESH:D001249
        label: Disease
        name: Asthma
    reference: https://go.drugbank.com/drugs/DB07615 https://pubchem.ncbi.nlm.nih.gov/compound/Tranilast#section=MeSH-Pharmacological-Classification https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1527-3466.1998.tb00359.x https://newdrugapprovals.org/2020/02/28/tranilast/
-   directed: true
    graph:
        drug: Tranilast
        drugbank: DB:DB07615
        drug_mesh: MESH:C012293
        disease: Allergic rhinitis
        disease_mesh: MESH:D065631
    links:
    -   key: decreases activity of
        source: MESH:C012293
        target: GO:0001821
    -   key: location of
        source: GO:0001821
        target: CL:0000097
    -   key: ameliorates
        source: CL:0000097
        target: GO:0002524
    -   key: decreases activity of
        source: GO:0002524
        target: GO:0048144
    -   key: correlated with
        source: GO:0048144
        target: MESH:D065631
    multigraph: true
    nodes:
    -   id: MESH:C012293
        label: Drug
        name: Tranilast
    -   id: GO:0001821
        label: BiologicalProcess
        name: Histamine secretion
    -   id: CL:0000097
        label: Cell
        name: Mast cell
    -   id: GO:0002524
        label: BiologicalProcess
        name: Hypersensitivity
    -   id: GO:0048144
        label: BiologicalProcess
        name: Fibroblast proliferation
    -   id: MESH:D065631
        label: Disease
        name: Allergic rhinitis
    reference: https://go.drugbank.com/drugs/DB07615 https://pubchem.ncbi.nlm.nih.gov/compound/Tranilast#section=MeSH-Pharmacological-Classification https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1527-3466.1998.tb00359.x https://newdrugapprovals.org/2020/02/28/tranilast/
-   directed: true
    graph:
        drug: Tranilast
        drugbank: DB:DB07615
        drug_mesh: MESH:C012293
        disease: Allergic rhinitis
        disease_mesh: MESH:D065631
    links:
    -   key: decreases activity of
        source: MESH:C012293
        target: UniProt:P35354
    -   key: decreases activity of
        source: UniProt:P35354
        target: GO:0001516
    -   key: decreases abundance of
        source: GO:0001516
        target: MESH:D044062
    -   key: decreases activity of
        source: MESH:C012293
        target: MESH:D016207
    -   key: ameliorates
        source: MESH:D016207
        target: GO:0006954
    -   key: ameliorates
        source: MESH:D044062
        target: GO:0006954
    -   key: correlated with
        source: GO:0006954
        target: MESH:D065631
    multigraph: true
    nodes:
    -   id: MESH:C012293
        label: Drug
        name: Tranilast
    -   id: UniProt:P35354
        label: Protein
        name: Cyclooxygenase-2
    -   id: GO:0001516
        label: BiologicalProcess
        name: Prostaglandin biosynthetic process
    -   id: MESH:D016207
        label: BiologicalProcess
        name: Cytokines release
    -   id: MESH:D044062
        label: ChemicalSubstance
        name: Prostaglandins I
    -   id: GO:0006954
        label: BiologicalProcess
        name: Inflammatory response
    -   id: MESH:D065631
        label: Disease
        name: Allergic rhinitis
    reference: https://go.drugbank.com/drugs/DB07615 https://pubchem.ncbi.nlm.nih.gov/compound/Tranilast#section=MeSH-Pharmacological-Classification https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1527-3466.1998.tb00359.x https://newdrugapprovals.org/2020/02/28/tranilast/

-   directed: true
    graph:
        drug: Tranilast
        drugbank: DB:DB07615
        drug_mesh: MESH:C012293
        disease: Atopic dermatitis
        disease_mesh: MESH:D003876
    links:
    -   key: decreases activity of
        source: MESH:C012293
        target: GO:0001821
    -   key: location of
        source: GO:0001821
        target: CL:0000097
    -   key: ameliorates
        source: CL:0000097
        target: GO:0002524
    -   key: decreases activity of
        source: GO:0002524
        target: GO:0048144
    -   key: correlated with
        source: GO:0048144
        target: MESH:D003876
    multigraph: true
    nodes:
    -   id: MESH:C012293
        label: Drug
        name: Tranilast
    -   id: GO:0001821
        label: BiologicalProcess
        name: Histamine secretion
    -   id: CL:0000097
        label: Cell
        name: Mast cell
    -   id: GO:0002524
        label: BiologicalProcess
        name: Hypersensitivity
    -   id: GO:0048144
        label: BiologicalProcess
        name: Fibroblast proliferation
    -   id: MESH:D003876
        label: Disease
        name: Atopic dermatitis
    reference: https://go.drugbank.com/drugs/DB07615 https://pubchem.ncbi.nlm.nih.gov/compound/Tranilast#section=MeSH-Pharmacological-Classification https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1527-3466.1998.tb00359.x https://newdrugapprovals.org/2020/02/28/tranilast/
-   directed: true
    graph:
        drug: Tranilast
        drugbank: DB:DB07615
        drug_mesh: MESH:C012293
        disease: Atopic dermatitis
        disease_mesh: MESH:D003876
    links:
    -   key: decreases activity of
        source: MESH:C012293
        target: UniProt:P35354
    -   key: decreases activity of
        source: UniProt:P35354
        target: GO:0001516
    -   key: decreases abundance of
        source: GO:0001516
        target: MESH:D044062
    -   key: decreases activity of
        source: MESH:C012293
        target: MESH:D016207
    -   key: ameliorates
        source: MESH:D016207
        target: GO:0006954
    -   key: ameliorates
        source: MESH:D044062
        target: GO:0006954
    -   key: correlated with
        source: GO:0006954
        target: MESH:D003876
    multigraph: true
    nodes:
    -   id: MESH:C012293
        label: Drug
        name: Tranilast
    -   id: UniProt:P35354
        label: Protein
        name: Cyclooxygenase-2
    -   id: GO:0001516
        label: BiologicalProcess
        name: Prostaglandin biosynthetic process
    -   id: MESH:D016207
        label: BiologicalProcess
        name: Cytokines release
    -   id: MESH:D044062
        label: ChemicalSubstance
        name: Prostaglandins I
    -   id: GO:0006954
        label: BiologicalProcess
        name: Inflammatory response
    -   id: MESH:D003876
        label: Disease
        name: Atopic dermatitis
    reference: https://go.drugbank.com/drugs/DB07615 https://pubchem.ncbi.nlm.nih.gov/compound/Tranilast#section=MeSH-Pharmacological-Classification https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1527-3466.1998.tb00359.x https://newdrugapprovals.org/2020/02/28/tranilast/
-   directed: true
    graph:
        drug: Tranilast
        drugbank: DB:DB07615
        drug_mesh: MESH:C012293
        disease: Keloid scar
        disease_mesh: MESH:D007627
    links:
    -   key: decreases activity of
        source: MESH:C012293
        target: GO:0001821
    -   key: location of
        source: GO:0001821
        target: CL:0000097
    -   key: ameliorates
        source: CL:0000097
        target: GO:0002524
    -   key: decreases activity of
        source: GO:0002524
        target: GO:0048144
    -   key: correlated with
        source: GO:0048144
        target: MESH:D007627
    multigraph: true
    nodes:
    -   id: MESH:C012293
        label: Drug
        name: Tranilast
    -   id: GO:0001821
        label: BiologicalProcess
        name: Histamine secretion
    -   id: CL:0000097
        label: Cell
        name: Mast cell
    -   id: GO:0002524
        label: BiologicalProcess
        name: Hypersensitivity
    -   id: GO:0048144
        label: BiologicalProcess
        name: Fibroblast proliferation
    -   id: MESH:D007627
        label: Disease
        name: Keloid scar
    reference: https://go.drugbank.com/drugs/DB07615 https://pubchem.ncbi.nlm.nih.gov/compound/Tranilast#section=MeSH-Pharmacological-Classification https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1527-3466.1998.tb00359.x https://newdrugapprovals.org/2020/02/28/tranilast/
-   directed: true
    graph:
        drug: Tranilast
        drugbank: DB:DB07615
        drug_mesh: MESH:C012293
        disease: Keloid scar
        disease_mesh: MESH:D007627
    links:
    -   key: decreases activity of
        source: MESH:C012293
        target: UniProt:P35354
    -   key: decreases activity of
        source: UniProt:P35354
        target: GO:0001516
    -   key: decreases abundance of
        source: GO:0001516
        target: MESH:D044062
    -   key: decreases activity of
        source: MESH:C012293
        target: MESH:D016207
    -   key: ameliorates
        source: MESH:D016207
        target: GO:0006954
    -   key: ameliorates
        source: MESH:D044062
        target: GO:0006954
    -   key: correlated with
        source: GO:0006954
        target: MESH:D007627
    multigraph: true
    nodes:
    -   id: MESH:C012293
        label: Drug
        name: Tranilast
    -   id: UniProt:P35354
        label: Protein
        name: Cyclooxygenase-2
    -   id: GO:0001516
        label: BiologicalProcess
        name: Prostaglandin biosynthetic process
    -   id: MESH:D016207
        label: BiologicalProcess
        name: Cytokines release
    -   id: MESH:D044062
        label: ChemicalSubstance
        name: Prostaglandins I
    -   id: GO:0006954
        label: BiologicalProcess
        name: Inflammatory response
    -   id: MESH:D007627
        label: Disease
        name: Keloid scar
    reference: https://go.drugbank.com/drugs/DB07615 https://pubchem.ncbi.nlm.nih.gov/compound/Tranilast#section=MeSH-Pharmacological-Classification https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1527-3466.1998.tb00359.x https://newdrugapprovals.org/2020/02/28/tranilast/
-   directed: true
    graph:
        drug: Tranilast
        drugbank: DB:DB07615
        drug_mesh: MESH:C012293
        disease: Hypertrophic scar
        disease_mesh: MESH:D017439
    links:
    -   key: decreases activity of
        source: MESH:C012293
        target: GO:0001821
    -   key: location of
        source: GO:0001821
        target: CL:0000097
    -   key: ameliorates
        source: CL:0000097
        target: GO:0002524
    -   key: decreases activity of
        source: GO:0002524
        target: GO:0048144
    -   key: correlated with
        source: GO:0048144
        target: MESH:D017439
    multigraph: true
    nodes:
    -   id: MESH:C012293
        label: Drug
        name: Tranilast
    -   id: GO:0001821
        label: BiologicalProcess
        name: Histamine secretion
    -   id: CL:0000097
        label: Cell
        name: Mast cell
    -   id: GO:0002524
        label: BiologicalProcess
        name: Hypersensitivity
    -   id: GO:0048144
        label: BiologicalProcess
        name: Fibroblast proliferation
    -   id: MESH:D017439
        label: Disease
        name: Hypertrophic scar
    reference: https://go.drugbank.com/drugs/DB07615 https://pubchem.ncbi.nlm.nih.gov/compound/Tranilast#section=MeSH-Pharmacological-Classification https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1527-3466.1998.tb00359.x https://newdrugapprovals.org/2020/02/28/tranilast/
-   directed: true
    graph:
        drug: Tranilast
        drugbank: DB:DB07615
        drug_mesh: MESH:C012293
        disease: Hypertrophic scar
        disease_mesh: MESH:D017439
    links:
    -   key: decreases activity of
        source: MESH:C012293
        target: UniProt:P35354
    -   key: decreases activity of
        source: UniProt:P35354
        target: GO:0001516
    -   key: decreases abundance of
        source: GO:0001516
        target: MESH:D044062
    -   key: decreases activity of
        source: MESH:C012293
        target: MESH:D016207
    -   key: ameliorates
        source: MESH:D016207
        target: GO:0006954
    -   key: ameliorates
        source: MESH:D044062
        target: GO:0006954
    -   key: correlated with
        source: GO:0006954
        target: MESH:D017439
    multigraph: true
    nodes:
    -   id: MESH:C012293
        label: Drug
        name: Tranilast
    -   id: UniProt:P35354
        label: Protein
        name: Cyclooxygenase-2
    -   id: GO:0001516
        label: BiologicalProcess
        name: Prostaglandin biosynthetic process
    -   id: MESH:D016207
        label: BiologicalProcess
        name: Cytokines release
    -   id: MESH:D044062
        label: ChemicalSubstance
        name: Prostaglandins I
    -   id: GO:0006954
        label: BiologicalProcess
        name: Inflammatory response
    -   id: MESH:D017439
        label: Disease
        name: Hypertrophic scar
    reference: https://go.drugbank.com/drugs/DB07615 https://pubchem.ncbi.nlm.nih.gov/compound/Tranilast#section=MeSH-Pharmacological-Classification https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1527-3466.1998.tb00359.x https://newdrugapprovals.org/2020/02/28/tranilast/
-   directed: true
    graph:
        drug: Tranilast
        drugbank: DB:DB07615
        drug_mesh: MESH:C012293
        disease: Keloid scar
        disease_mesh: MESH:D007627
    links:
    -   key: decreases synthesis of
        source: MESH:C012293
        target: InterPro:IPR015618
    -   key: decreases activity of
        source: InterPro:IPR015618
        target: GO:0032964
    -   key: located in
        source: GO:0032964
        target: CL:0000057
    -   key: prevents
        source: CL:0000057
        target: GO:0048144
    -   key: manifestation of
        source: GO:0048144
        target: MESH:D007627
    multigraph: true
    nodes:
    -   id: MESH:C012293
        label: Drug
        name: Tranilast
    -   id: InterPro:IPR015618
        label: GeneFamily
        name: Transforming growth factor beta-3
    -   id: GO:0032964
        label: BiologicalProcess
        name: Collagen biosynthetic process
    -   id: CL:0000057
        label: Cell
        name: Fibroblast
    -   id: GO:0048144
        label: BiologicalProcess
        name: Fibroblast proliferation
    -   id: MESH:D007627
        label: Disease
        name: Keloid scar
    reference: https://go.drugbank.com/drugs/DB07615 https://pubchem.ncbi.nlm.nih.gov/compound/Tranilast#section=MeSH-Pharmacological-Classification https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1527-3466.1998.tb00359.x https://newdrugapprovals.org/2020/02/28/tranilast/
-   directed: true
    graph:
        drug: Tranilast
        drugbank: DB:DB07615
        drug_mesh: MESH:C012293
        disease: Hypertrophic scar
        disease_mesh: MESH:D017439
    links:
    -   key: decreases synthesis of
        source: MESH:C012293
        target: InterPro:IPR015618
    -   key: decreases activity of
        source: InterPro:IPR015618
        target: GO:0032964
    -   key: located in
        source: GO:0032964
        target: CL:0000057
    -   key: prevents
        source: CL:0000057
        target: GO:0048144
    -   key: manifestation of
        source: GO:0048144
        target: MESH:D017439
    multigraph: true
    nodes:
    -   id: MESH:C012293
        label: Drug
        name: Tranilast
    -   id: InterPro:IPR015618
        label: GeneFamily
        name: Transforming growth factor beta-3
    -   id: GO:0032964
        label: BiologicalProcess
        name: Collagen biosynthetic process
    -   id: CL:0000057
        label: Cell
        name: Fibroblast
    -   id: GO:0048144
        label: BiologicalProcess
        name: Fibroblast proliferation
    -   id: MESH:D017439
        label: Disease
        name: Hypertrophic scar
    reference: https://go.drugbank.com/drugs/DB07615 https://pubchem.ncbi.nlm.nih.gov/compound/Tranilast#section=MeSH-Pharmacological-Classification https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1527-3466.1998.tb00359.x https://newdrugapprovals.org/2020/02/28/tranilast/

